Literature DB >> 27387674

Pseudomonas aeruginosa identified as a key pathogen in hospitalised children with aspiration pneumonia and a high aspiration risk.

Liat Ashkenazi-Hoffnung1,2, Anne Ari1, Efraim Bilavsky1,2, Oded Scheuerman1,2, Jacob Amir1,2, Dario Prais1,2.   

Abstract

AIM: Data on the causative pathogens and optimal empirical therapy of aspiration pneumonia in children are limited. This study sought to describe the bacteriology of aspiration pneumonia in hospitalised children with a high aspiration risk.
METHODS: Respiratory tract specimens were prospectively collected using the induced sputum technique from children with a high aspiration risk who were hospitalised for aspiration pneumonia in a tertiary paediatric medical centre from 2009 to 2014. Clinical, microbiological and treatment data were recorded and analysed for each admission.
RESULTS: The cohort comprised 50 children with 235 hospital admissions. Of the 183 respiratory tract cultures performed, 110 were positive for bacteria, with 169 isolates, mostly Gram-negative. The most common Gram-negative pathogen was Pseudomonas aeruginosa. If patients had Pseudomonas aeruginosa isolation, the risk of them having the pathogen again was 81%. The multivariate analysis showed that the use of antibiotic prophylaxis and number of hospitalisations were significantly associated with Pseudomonas aeruginosa isolation.
CONCLUSION: Gram-negative bacilli, especially Pseudomonas aeruginosa, were the major causative agents of paediatric aspiration pneumonia in our study. Empiric antipseudomonas treatment should be considered, particularly in patients who are receiving antibiotic prophylaxis, have experienced recurrent hospitalisations or with previous respiratory cultures that showed Pseudomonas aeruginosa isolation. ©2016 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Pseudomonas aeruginosazzm321990; Induced sputum; Neurologically impaired children; Respiratory infection; Respiratory tract culture

Mesh:

Substances:

Year:  2016        PMID: 27387674     DOI: 10.1111/apa.13523

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  Length of Stay and Hospital Revisit After Bacterial Tracheostomy-Associated Respiratory Tract Infection Hospitalizations.

Authors:  Christopher J Russell; Mary R Mamey; Joyce Y Koh; Sheree M Schrager; Michael N Neely; Susan Wu
Journal:  Hosp Pediatr       Date:  2018-01-16

2.  Antibiotics for Aspiration Pneumonia in Neurologically Impaired Children.

Authors:  Joanna Thomson; Matt Hall; Lilliam Ambroggio; Jay G Berry; Bryan Stone; Rajendu Srivastava; Samir S Shah
Journal:  J Hosp Med       Date:  2019-11-20       Impact factor: 2.960

3.  Reducing the frequency of respiratory tract infections in severe neurological disorders by inhaled antibiotics: a retrospective data analysis.

Authors:  Maximilian Eckerland; Claudia Bock; Margarete Olivier; Leopold Pichlmaier; Mathis Steindor; Florian Stehling
Journal:  ERJ Open Res       Date:  2019-07-22

4.  Development of Chronic Pseudomonas aeruginosa-Positive Respiratory Cultures in Children with Tracheostomy.

Authors:  Christopher J Russell; Tamara D Simon; Michael N Neely
Journal:  Lung       Date:  2019-10-31       Impact factor: 3.777

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.